Additional chemotherapeutic approaches such as antimetabolic drugs, hormone therapy, or bevacizumab (for patients with VEGF overexpression) are recommended to enhance cancer removal but offer limited success rates [37,38]. The gene discussed is VEGFA; the disease is cancer.